Migraine Awareness Week 2025: Insights from BMC Series Journals
Published in General & Internal Medicine and Public Health
Migraine isn’t just a headache; it is a complex neurological disorder that affects over one billion people worldwide and ranks among the leading causes of disability. Its symptoms including intense head pain, visual disturbances, nausea, fatigue, and sensitivity to light or sound can severely disrupt daily life, making it difficult to work, study, or maintain relationships. Despite this global impact, migraine remains under-recognized, under-diagnosed, and under-treated in many healthcare systems.
In this blog, we spotlight recent publications from BMC Series journals, including BMC Neurology and BMC Public Health, that highlight three critical aspects of living with migraine: the stigma faced by individuals with migraine, the population-level burden and unmet needs in care, and the influence of lifestyle factors in the digital era on migraine severity.
BMC Neurology - Stigmatizing attitudes toward people with migraine by people without active migraine: results of the OVERCOME (US) study
Migraine is not only a disabling neurological disorder but also one that carries stigma. Because it is an “invisible” condition, many people with migraine feel dismissed by the family and the society who may consider their condition insignificant. This external stigma adds to the emotional and social burden of living with migraine.
A recent study published in BMC Neurology explored stigmatizing attitudes towards people with migraine using data from the ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) US study, a population-based web survey. The study found that 70% of people without active migraine endorsed at least one stigmatizing attitude toward those with migraine. Stigmatizing attitudes were more common among people who had a history of migraine or close contact with someone who had migraine. These findings show that people with migraine face stigma from both those who experience migraine and those who do not, highlighting the importance of raising awareness and building supportive environments.

©Fizkes/Getty Images/iStock
BMC Public health - The epidemiology and unmet need of migraine in five european countries: results from the national health and wellness survey
Migraine is the second leading cause of disability worldwide and affects more than 1.1 billion people. Despite its high prevalence, migraines often remain under-diagnosed and under-treated, leading to poor health outcomes and increased economic burden.
A recent study published in BMC Public Health assessed the burden of migraine in five European countries - France, Germany, the UK, Italy, and Spain, using patient-reported data from the National Health and Wellness Survey. The study found that migraine affects about 11.5% of adults, with Spain reporting the highest rates. The highest prevalence was seen among adults aged 30–39 years, and women were twice as likely as men to experience migraine. Nearly one-fourth of diagnosed respondents reported more than four monthly migraine days, and over half had more than four monthly headache days. Despite available treatments, most patients were managed by primary care physicians with a strong reliance on painkillers, reflecting high rates of medication overuse and gaps in referral and specialist care. These results highlight a significant treatment gap in Europe and the need for improved management strategies.

©SARINYAPINNGAM/Getty Images/iStock
BMC public health - Internet use May be associated with the severity of headache in migraine patients: results from a Hungarian tertiary headache center
Along with stress, poor posture, and diet, digitalization has emerged as a lifestyle factor that may influence migraine. Excessive use of screens and internet-based activities has been linked to both the frequency and severity of migraine attacks, with patterns resembling behavioral addiction.
A recent questionnaire-based cross-sectional study from Hungary, published in BMC Public Health, examined how internet use patterns affect migraine severity. The study found that individuals who used the internet between 9 pm and midnight were more likely to experience severe migraine attacks. Nighttime use, often a sign of internet addiction, was also associated with sleep deprivation and insomnia. Online gaming was particularly linked with more severe headaches. These findings suggest that reducing late-night screen time and prioritizing healthy sleep habits may help prevent or lessen migraine severity. The study highlights how digital habits are an important part of migraine management in modern life.

©Motortion/Getty Images/iStock
Making the Invisible Visible
The 2025 campaign theme for Migraine Awareness, “I AM (IN)VISIBLE,” is a powerful reminder that although migraine cannot be seen, its effects are profound. Research from the BMC Series underscores the urgent need to raise awareness and create supportive environments for people with migraine, helping reduce its global burden and improve the quality of life for millions.
Follow the Topic
-
BMC Public Health
An open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health.
-
BMC Neurology
This is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of neurological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With Collections, you can get published faster and increase your visibility.
Advances in neurocritical care: monitoring, management, and outcomes
Neurocritical care is at a crucial juncture, with the rising incidence of acute brain injuries and strokes, highlighting the need for ongoing advancements. Innovative techniques, such as advanced neuromonitoring and intracranial pressure (ICP) monitoring, enable real-time assessments, leading to timely interventions that improve patient survival and quality of life.
Standardized protocols in Neuro-ICUs enhance multidisciplinary collaboration and optimize management of critical factors, while the use of artificial intelligence (AI) continues to revolutionize clinical decision-making. Research in this field must persist in addressing the complexities of acute stroke and brain injury, paving the way for minimally invasive monitoring, novel therapeutic strategies, and personalized rehabilitation approaches.
Engaging the community in neurocritical care discussions is essential for fostering awareness and support. We invite researchers to contribute to the BMC Neurology Collection.
Topics of interest include but are not limited to:
-
- Advances in neuromonitoring techniques
- Best practices in neuro-ICU management
- Outcomes measurement in neurocritical care
- Predictive AI in neurocritical care
- Innovative approaches to acute stroke management
- Patient-Centered care models in neurology
- Intracranial pressure management strategies
- Neuroprotection and rehabilitation interventions
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: May 13, 2027
Neuroimaging in neurological disorders
Neurological disorders affect millions of individuals worldwide and pose major challenges for healthcare systems. Advances in neuroimaging provide powerful tools to investigate the underlying mechanisms of these disorders, enabling earlier and more accurate diagnosis, better monitoring of disease progression, and improved evaluation of treatment responses.
A wide range of imaging modalities are now available, from magnetic resonance imaging (MRI), Functional magnetic resonance imaging (fMRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), diffusion tensor imaging (DTI), magnetic resonance spectroscopy (MRS), electroencephalogram (EEG), magnetoencephalography (MEG), and near-infrared spectroscopy (NIRS). Emerging methods, such as amyloid and tau imaging, perfusion imaging, connectomics, and machine learning–driven analyses, offer new opportunities to identify imaging biomarkers and link them with clinical outcomes.
By integrating imaging markers with clinical and biological data, researchers can enhance diagnostic precision, predict progression, and support personalized treatment approaches across a broad spectrum of conditions, including multiple sclerosis, Alzheimer’s disease, epilepsy, stroke, traumatic brain injury, amyotrophic lateral sclerosis, and other neurological disorders.
This Collection aims to showcase cutting-edge research that advances the use of neuroimaging in clinical practice and contributes to improved patient outcomes.
Topics of interest include, but are not limited to:
- Structural and functional imaging in neurological disorders
- Imaging biomarkers for diagnosis, prognosis, and treatment monitoring
- Molecular and metabolic imaging approaches
- Diffusion imaging and tractography in white matter disorders
- Multimodal imaging integration
- Machine learning and AI applications in neuroimaging
- Longitudinal imaging studies of disease progression
- Comparative studies across imaging modalities
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Apr 09, 2027